BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38330829)

  • 1. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma.
    Ma Z; Yi Y; Qiu Z
    Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017.
    van Doeveren T; van der Mark M; van Leeuwen PJ; Boormans JL; Aben KKH
    BJU Int; 2021 Sep; 128(3):343-351. PubMed ID: 33690922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985-2010.
    Eylert MF; Hounsome L; Verne J; Bahl A; Jefferies ER; Persad RA
    BJU Int; 2013 Jul; 112(2):E107-13. PubMed ID: 23470094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic nomogram for the cancer-specific survival of patients with upper-tract urothelial carcinoma based on the Surveillance, Epidemiology, and End Results Database.
    Li C; Yang J; Xu F; Han D; Zheng S; Kaaya RE; Wang S; Lyu J
    BMC Cancer; 2020 Jun; 20(1):534. PubMed ID: 32513124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Survival Rates of Contemporary Patients with Invasive Upper Tract Urothelial Carcinoma.
    Collà Ruvolo C; Nocera L; Stolzenbach LF; Wenzel M; Cucchiara V; Tian Z; Shariat SF; Saad F; Longo N; Montorsi F; Briganti A; Mirone V; Karakiewicz PI
    Eur Urol Oncol; 2021 Oct; 4(5):792-801. PubMed ID: 33293235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival outcomes for patients with localised upper tract urothelial carcinoma managed with non-definitive treatment.
    Syed JS; Nguyen KA; Suarez-Sarmiento A; Johnson K; Leapman MS; Raman JD; Shuch B
    BJU Int; 2018 Jan; 121(1):124-129. PubMed ID: 28972702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria--Australia.
    Woodford R; Ranasinghe W; Aw HC; Sengupta S; Persad R
    BJU Int; 2016 Apr; 117 Suppl 4():45-9. PubMed ID: 26486693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
    Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
    Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma.
    Paciotti M; Nguyen DD; Modonutti D; Haeuser L; Lipsitz S; Mossanen M; Kibel AS; Lughezzani G; Trinh QD; Cole AP
    Urol Oncol; 2021 Jul; 39(7):436.e1-436.e10. PubMed ID: 33736978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S; Preisser F; Mazzone E; Tian Z; Mistretta FA; Shariat SF; Soulières D; Saad F; Montanari E; Luzzago S; Briganti A; Carmignani L; Karakiewicz PI
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M; Badalato GM; Gupta M; McKiernan JM
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
    Wang Y; He HY
    Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival Outcomes in Neoadjuvant Chemotherapy for High-grade Upper Tract Urothelial Carcinoma: A Nationally Representative Analysis.
    Khan AI; Taylor BL; Al Hussein Al Awamlh B; Posada Calderon L; Fainberg J; Elahjji R; Shoag J; Scherr DS
    Urology; 2020 Dec; 146():158-167. PubMed ID: 32896584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the Upper Tract Urothelial Carcinoma Collaboration.
    Necchi A; Lo Vullo S; Mariani L; Moschini M; Hendricksen K; Rink M; Sosnowski R; Dobruch J; Raman JD; Wood CG; Margulis V; Roupret M; Briganti A; Montorsi F; Xylinas E; Shariat SF;
    BJU Int; 2018 Feb; 121(2):252-259. PubMed ID: 28940605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Patterns, Outcomes, and Costs Associated With Localized Upper Tract Urothelial Carcinoma.
    Fero KE; Shan Y; Lec PM; Sharma V; Srinivasan A; Movva G; Baillargeon J; Chamie K; Williams SB
    JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.